Dr Pauline Williams leads global health research and development at GSK and recently became an MRC Council member. Here she tells us about mixing science with business, and the satisfaction of making a life-saving gel from an antiseptic mouthwash.
Dr Pauline Williams, GlaxoSmithKline. Image credit: GlaxoSmithKline
Career in brief:
- Medicine degree, University of Cardiff
- Clinical Pharmacology physician, Glaxo Phase I Unit
- Head of Academic Discovery Performance Unit, GSK
- Senior Vice President and Head of Global Health R&D, GSK
It was the rigour and excitement of early drug development that tempted me away from medicine. I did a stint at a Phase I Clinical Pharmacology Unit after my medical training – and following that I was enticed by an offer to join Glaxo (now GSK) where I’ve worked ever since. My first role was a full immersion in the design, conduct and reporting of experimental medicine studies which has stood me in good stead throughout my career.
Career in brief:
- Medical school at the University of Oxford
- Academic foundation doctor for two years at the Bristol Royal Infirmary
- Clinical Research Fellow at the Mid-Atlantic Wellness Institute, Bermuda
- Research Fellow at the National Clinical Guideline Centre, London
- Academic Clinical Fellow and Speciality Training (currently year 4) in General Adult Psychiatry at the Maudsley Hospital, London
Addiction is an area where you can offer genuinely holistic care to patients. Patients with addiction disorders are often marginalised by society and within the health service. Being able to give good quality care to people who would otherwise struggle to access it is exceptionally rewarding. Patient care includes on-site sexual health, drug, alcohol and medical services.
At the moment I dedicate three days a week to clinical time and two days to research but when my MRC Addiction Research Clinical Fellowship starts I’ll be able to dedicate more time to research. Working at a national specialist service at the Maudsley Hospital, I see patients with depression and bipolar disorder whose treatment hasn’t worked. Read more
For World TB Day 2017 Sarah Harrop looks back at 104 years of MRC-funded tuberculosis (TB) research, a history that unites scientists, industry, policy-makers and patients with a shared goal of ending TB.